William D. Chey, MD Professor of Internal Medicine William Chey, MD 1/2/2020 1 William D. Chey, MD...

download William D. Chey, MD Professor of Internal Medicine William Chey, MD 1/2/2020 1 William D. Chey, MD Professor

of 103

  • date post

    13-Aug-2020
  • Category

    Documents

  • view

    3
  • download

    0

Embed Size (px)

Transcript of William D. Chey, MD Professor of Internal Medicine William Chey, MD 1/2/2020 1 William D. Chey, MD...

  • William Chey, MD 1/2/2020 1

    William D. Chey, MD

    Professor of Internal Medicine

    Director, GI Physiology Laboratory

    3912 Taubman Center, SPC 5362

    Ann Arbor, MI 48109

    734-936-4780

    wchey@med.umich.edu

    Title and Contents Page 1

    Education and Training Page 2

    Certification and Licensure Page 2

    Academic, Administrative, and Clinical Appointments Page 2

    Research Interests Page 2

    Grants/Patents Page 3

    Honors and Awards Page 10

    Memberships in Professional Societies Page 12

    Editorial Positions, Boards, and Peer-Review Service Page 12

    Teaching Page 13

    Committee, Organizational, and Volunteer Service Page 15

    Consulting Positions Page 17

    Visiting Professorships, Seminars, and Extramural Invited Presentations Page 17

    Bibliography Page 30

    mailto:wchey@med.umich.edu

  • William Chey, MD 1/2/2020 2

    Education and Training

    09/1978-05/1982 University of Pennsylvania, Bachelor of Arts in Biology

    09/1982-06/1986 Emory University School of Medicine, MD

    07/1986-06/1989 Residency Training in Internal Medicine, Emory Affiliated

    Hospitals

    07/1990-06/1993 Fellowship in Gastroenterology, University of Michigan

    Certification and Licensure

    Diplomat of NBME (7/87)

    Licensed to Practice Medicine in the State of Michigan (#4301056884), Expire 01/31/2018

    American Board of Internal Medicine Certification, 1989

    American Board of Internal Medicine Subspecialty Certification in Gastroenterology, 1993,

    Successful recertification 2003, 2013

    Academic, Administrative, and Clinical Appointments

    Academic

    07/1989-06/1990 Senior Associate, Department of Internal Medicine,

    Emory University School of Medicine, Atlanta, Georgia

    07/1993-08/1996 Lecturer in Internal Medicine,

    University of Michigan, Ann Arbor, Michigan

    09/1996-08/2001 Assistant Professor, Department of Internal Medicine,

    University of Michigan, Ann Arbor, Michigan

    09/2001-08/2007 Associate Professor, Department of Internal Medicine,

    University of Michigan, Ann Arbor, Michigan

    09/2007-present Professor, Department of Internal Medicine, University of

    Michigan, Ann Arbor, Michigan

    02/2015-present Timothy T. Nostrant Collegiate Professorship in

    Gastroenterology, Department of Internal Medicine,

    University of Michigan, Ann Arbor, Michigan

    07/2015- present Professor, Department of Nutritional Sciences, University of

    Michigan, Ann Arbor, Michigan

    Clinical

    07/1993-present Director, GI Physiology Laboratory,

    University of Michigan Health System

    Ann Arbor, Michigan

    01/2009-present Co-Director, Michigan Bowel Control Program

    University of Michigan Health System

    Ann Arbor, Michigan

  • William Chey, MD 1/2/2020 3

    01/2015-present Director, Digestive Diseases Nutrition & Behavioral Health

    Program, Division of Gastroenterology, University of

    Michigan Health System, Ann Arbor, Michigan

    09/2018-present Director, University of Michigan Food for Life Kitchen

    Private Sector Appointments

    Co-Founder and Co-CMO My Total Health, Los Angeles, California

    Research Interests 1. The pathophysiology and management of functional bowel disorders 2. The role of diet and nutrition in functional bowel and motility disorders 3. The emerging role of health information technology in medicine 4. Diagnosis and treatment of Helicobacter pylori and acid-peptic disorders

    Active Research Funding: IBS

    Sponsor: Vibrant

    Title: “A prospective, Multicenter, Randomized, Sample Size Adaptive,

    Single Blind, Placebo-Controlled Study to Assess the Efficacy and

    Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of

    Chronic Idiopathic Constipation (CIC)”

    Principal Investigator: William D. Chey, MD

    Funding period: 8/1/19-10/1/19 ($77,933)

    Sponsor: Urovant

    Title: “A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12

    Weeks to Women with Irritable Bowel Syndrome”

    Principal Investigator: William D. Chey, MD

    Funding period: 5/1/19-9/14/20 ($106,314)

    Sponsor: Biomerica

    Title: “An antibody guided dietary restriction trial using Biomerica InFoods 24G test in patients with Irritable Bowel Syndrome”

    Principal Investigator: William D. Chey, MD

    Funding period: 7/1/18-9/30/19 ($181,015)

    Sponsor: Commonwealth Diagnostics International

    Title: “The role of breath testing in enriching the likelihood of response

    to rifaximin in patients with non-constipated IBS”

    Principal Investigator: William D. Chey, MD

    Co-investigator: Borko Nojkov, MD

    Funding period: 9/10/19-8/31/21 ($155,122)

    Sponsor: QOL Medical

  • William Chey, MD 1/2/2020 4

    Title: “Sucrase-Isomaltase Deficiency in Irritable Bowel Syndrome and

    Diarrhea - Hiding in Plain Sight?” Principal Investigator: Shanti Eswaran, MD

    Project Mentor: William D. Chey, MD

    Funding period: 4/1/19-3/30/20 ($150,676)

    Sponsor: ACG Institute

    Title: “Low FODMAP plus PEG 3350 for the treatment of patients with Irritable Bowel Syndrome-Constipation”

    Principal Investigator: Stacy Menees, MD

    Project Mentor: William D. Chey, MD

    Funding period: 7/1/18-9/30/19 ($56,151)

    Sponsor: Nestle HealthCare Nutrition

    Title: “Charting a course to a less restrictive diet for IBS patients”

    Principal Investigator: Shanti Eswaran, MD

    Project Mentor: William D. Chey, MD

    Funding period: 11/4/17-9/30/19 ($116,248)

    Sponsor: MICHR Pilot Grant Program

    Title: “Charting a course to a less restrictive diet for IBS patients”

    Principal Investigator: Shanti Eswaran, MD

    Project Mentor: William D. Chey, MD

    Funding period: 1/1/17-1/1/18 ($50,000)

    Chronic Constipation:

    Sponsor: Vibrant

    Title: “A Prospective, Randomized, Multi-center, Single-Blinded,

    Placebo-Controlled, 3-Arm Clinical Study to Assess the Efficacy

    and Safety of Vibrant Capsule for the Treatment of Chronic

    Idiopathic Constipation”

    Principal Investigator: William D. Chey, MD

    Co-investigators: Shanti Eswaran, Borko Nojkov

    Funding period: 1/22/19 – 9/30/19 ($77,933)

    Sponsor: UM Fast Forward GI Innovation Fund

    Title: “Tier II – Development of an office-based, disposable rectal expulsion device to screen for dyssynergic defecation in

    constipated patients” Principal Investigator: William D. Chey, MD

    Project Mentor: Eric Shah, MD

    Funding period: 7/1/18-6/30/19 ($100,000)

    Sponsor: Zespri

    Title: “A randomized, controlled pilot study to compare the efficacy of Kiwifruit,

    prunes, or psyllium on abdominal and bowel symptoms in US patients

  • William Chey, MD 1/2/2020 5

    with chronic constipation”

    Principal Investigator: Shanti Eswaran, MD

    Project Mentor: William D. Chey, MD

    Funding period: 5/1/18-9/1/19 ($176,844)

    Other:

    Sponsor: Craig H. Nelson Foundation

    Title: “The Wireless Motility Capsule for Neurogenic Bowel in Spinal

    Cord Injury”

    Principal Investigator: Gianna Rodriguez, MD

    Co-investigators: William D. Chey, MD, Jason Baker, Richard Saad, MD

    Funding period: 7/31/17-7/30/19 ($300,000)

    Past

    GCRC-CAP Award for "Visceral Afferent Dysfunction in Diabetic Constipation",

    Principal Investigator: WD Chey

    Funding period from 4/1/94 to 3/31/97 ($196,400)

    Glaxo Institute of Digestive Health Clinical Research Award for "Role of Hyperglycemia on

    Efferent Neural and Myogenic Function in the Human Colon",

    Principal Investigator: WD Chey

    Funding period from 7/1/94 to 6/30/95 ($40,000)

    Glaxo Institute of Digestive Health Clinical Research Award for "Visceral Afferent Neural

    Dysfunction in Diabetic Constipation",

    Principal Investigator: WD Chey

    Funding period from 7/1/95 to 6/30/96 ($39,000)

    Sandoz Pharma Ltd for "A randomized, double-blind, placebo-controlled, multicenter, dose

    ranging study to assess the safety and efficacy of SDZ HTF 919 at four dose levels in subjects

    with constipation-prone irritable bowel syndrome"

    Principal Investigator: Chung Owyang, MD

    Co-investigators: WD Chey, JL Barnett, G Elta, W Hasler, T Nostrant, J Scheiman,

    J Wiley.

    Funding period from 4/95 to 2/96 ($97,988)

    Astra-Merck for "Prolonged effect of omeprazole on the 14C-urea breath test",

    Principal Investigator: WD Chey

    Funding period from 5/95 to 1/96 ($4,200)

    Chemtrak for "Accumeter H. pylori test: Cut-off verification, clinical performance, and

    reproducibility",

    Principal Investigator: WD Chey.

    Funding period from 8/95 to 2/96 ($26,500)

  • William Chey, MD 1/2/2020 6